NCT06741618 MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
| NCT ID | NCT06741618 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | HIV/AIDS |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2026-04-20 |
| Primary Completion | 2028-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2026-04-20 with a primary completion date of 2028-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
MyPEEPS Mobile Plus, a multi-level intervention for improving HIV prevention outcomes in YMSM, is a novel and evidence-driven approach using mobile technology to deliver HIV prevention information specifically developed for YMSM. Building on strong preliminary work, the proposed research is the next logical step in a body of work designed to assess whether refinement of this mobile intervention used in combination with virtual PrEP Peer Navigation will result in improvements in PrEP uptake and a reduction in HIV-related behavior. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.
Eligibility Criteria
Inclusion Criteria: * 16-25 years of age * identify as male or non-binary * male sex assigned at birth * understand and read English * own a smartphone * report condomless anal sex with a male in the past year * HIV-negative (OraQuick verified) Exclusion Criteria: * HIV Positive * If study staff determine participant unable to consent due to obvious and severe cognitive impairment or under the influence of drugs or alcohol * currently report consistent use of PrEP * currently enrolled in another HIV prevention study
Contact & Investigator
Robert Garofalo, MD, MPH
PRINCIPAL INVESTIGATOR
Ann & Robert H Lurie Children's Hospital of Chicago
Frequently Asked Questions
Who can join the NCT06741618 clinical trial?
This trial is open to male participants only, aged 16 Years or older, up to 25 Years, studying HIV/AIDS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06741618 currently recruiting?
Yes, NCT06741618 is actively recruiting participants. Contact the research team at rb897@columbia.edu for enrollment information.
Where is the NCT06741618 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06741618 clinical trial?
NCT06741618 is sponsored by Columbia University. The principal investigator is Robert Garofalo, MD, MPH at Ann & Robert H Lurie Children's Hospital of Chicago. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.